Sorafenib synergizes with metformin in NSCLC through AMPK pathway activation
International Journal of Cancer (2015) - Comments
pubmed: 25080865  doi: 10.1002/ijc.29113  issn: 1097-0215  issn: 0020-7136 

Floris H. Groenendijk, Wouter W. Mellema, Eline Van Der Burg, Eva Schut, Michael Hauptmann, Hugo M. Horlings, Stefan M. Willems, Michel M. Van Den Heuvel, Jos Jonkers, Egbert F. Smit, René Bernards